Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9237 |
High Similarity |
NPD3027 |
Phase 3 |
0.875 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD1613 |
Approved |
0.8519 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD37 |
Approved |
0.8085 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8085 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8058 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7986 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7935 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7935 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7914 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD228 |
Approved |
0.777 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7754 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7708 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7698 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7698 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7681 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7634 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7634 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7595 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7468 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7417 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.74 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7329 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7321 |
Intermediate Similarity |
NPD7240 |
Approved |
0.732 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7285 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7285 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7285 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7237 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7211 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7211 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7179 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD7157 |
Approved |
0.717 |
Intermediate Similarity |
NPD4678 |
Approved |
0.717 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7164 |
Intermediate Similarity |
NPD2684 |
Approved |
0.716 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD846 |
Approved |
0.7099 |
Intermediate Similarity |
NPD940 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7093 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7093 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7093 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD290 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD4538 |
Approved |
0.708 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7067 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7067 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7067 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD27 |
Approved |
0.7066 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7063 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD3092 |
Approved |
0.705 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7048 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7032 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7025 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7023 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.702 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7014 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7014 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7014 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1240 |
Approved |
0.6987 |
Remote Similarity |
NPD6190 |
Approved |
0.6977 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6962 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD2534 |
Approved |
0.6962 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6962 |
Remote Similarity |
NPD2532 |
Approved |
0.6962 |
Remote Similarity |
NPD2533 |
Approved |
0.6957 |
Remote Similarity |
NPD7635 |
Approved |
0.6954 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD3020 |
Approved |
0.6946 |
Remote Similarity |
NPD3051 |
Approved |
0.6946 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6936 |
Remote Similarity |
NPD7312 |
Approved |
0.6936 |
Remote Similarity |
NPD4577 |
Approved |
0.6936 |
Remote Similarity |
NPD7310 |
Approved |
0.6936 |
Remote Similarity |
NPD4578 |
Approved |
0.6936 |
Remote Similarity |
NPD7311 |
Approved |
0.6936 |
Remote Similarity |
NPD7313 |
Approved |
0.6933 |
Remote Similarity |
NPD7819 |
Suspended |
0.6933 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6929 |
Remote Similarity |
NPD709 |
Approved |
0.6928 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD5588 |
Approved |
0.6928 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD2156 |
Approved |
0.6928 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD2154 |
Approved |
0.6928 |
Remote Similarity |
NPD2155 |
Approved |
0.6923 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6918 |
Remote Similarity |
NPD1283 |
Approved |
0.6909 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6908
|
Remote Similarity |
NPD1607 |
Approved |